Related Experiment Videos
Dipyridamole-induced epistaxis
Summary
Dipyridamole can cause severe nosebleeds (epistaxis) by affecting platelet aggregation. Stopping the drug and normalizing platelet function resolved the bleeding, highlighting a potential complication, especially in elderly patients.
Area of Science:
- Pharmacology
- Hematology
- Clinical Medicine
Background:
- Dipyridamole is a medication used to prevent blood clots.
- Platelet aggregation is crucial for hemostasis.
Observation:
- A patient on dipyridamole experienced severe epistaxis.
- Platelet aggregation tests showed abnormalities during the event.
Findings:
- The epistaxis was unresponsive to conventional local treatments.
- Bleeding ceased only after discontinuing dipyridamole and observing platelet function normalization.
Implications:
- Severe epistaxis should be recognized as a potential adverse effect of dipyridamole.
- Clinicians should consider dipyridamole-induced platelet dysfunction in cases of unexplained hemorrhage, particularly in elderly individuals.